Evidence map›Paper›PMID 41593810›Full record

Trial reportAdvances in rheumatology (London, England)2026

A comparative study of the efficacy of single and double centrifuged platelet-rich plasma and placebo (normal saline injection) on pain, ROM, and physical function of patients with knee osteoarthritis: a double-blinded controlled randomized trial with a six-month follow-up.

Paniz Jahani, Hooman Angoorani, Azar Moezy, Marzieh Fazlinejad, Ali Mazaherinezhad

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Advances in rheumatology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paniz JahaniDepartment of Sports and Exercise Medicine, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran.
Hooman AngooraniDepartment of Sports and Exercise Medicine, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran.
Azar MoezyDepartment of Sports and Exercise Medicine, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran.
Marzieh FazlinejadDepartment of Sports and Exercise Medicine, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran.
Ali MazaherinezhadDepartment of Sports and Exercise Medicine, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran. mazaherinezhad@gmail.com.ORCID http://orcid.org/0000-0002-2771-2994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConsidering the effectiveness of platelet-rich plasma (PRP) in the treatment of knee osteoarthritis and the existence of different methods of preparing PRP, it is necessary to investigate various techniques as well as the number of leukocytes and platelets in the solutions prepared with these techniques and their effectiveness. PURPOSE: This study aimed to compare the effectiveness of PRP obtained through single centrifuged or double centrifuged methods, as well as a placebo injection, in addressing pain, range of motion, and physical performance in patients with knee osteoarthritis. STUDY

designThis study was a double-blind, randomized Controlled clinical trial.

methodsA randomized controlled trial enrolled 45 participants aged 50 to 75 years diagnosed with knee osteoarthritis, in the years 2021–2022, at the Sports and exercise Medicine Clinic. The participants were randomly assigned to one of three groups: platelet-rich plasma injection, single centrifuged PRP, double centrifuged PRP, or normal saline as a placebo. Pain intensity, knee range of motion, functional tests, and WOMAC Questionnaire scores were evaluated before and after one, three, and six months of the intervention. Statistical analyses were employed to assess the data and identify any superior group post-intervention and during the follow-up period.

resultsThe findings of this investigation demonstrated notable variations among the groups in the ROM 122.14 ± 6.71 (p = 0.001) and Stair-up 25.21 ± 9.45 (p = 0.014) variables one month after the intervention in double-centrifuged group and ROM 118.92 ± 11.95 (p = 0.001) in single-centrifuged group compared to the control group. Furthermore, there was significant improvement (p < 0.05) in the majority of variables within the single and double centrifuged groups compared to the control group at three and six-months post-intervention. Nevertheless, no significant differences were observed in any of the variables between the single and double centrifuged groups except the Stair-Up test after six-month post-intervention.

conclusionPlatelet-rich plasma (PRP) exhibits the capacity to enhance pain relief, increase range of motion, and ameliorate function and WOMAC scores in knee osteoarthritis. Both single and double centrifuged PRP methodologies yield comparable effects, but double centrifugation yields more prompt positive outcomes. Consequently, both techniques are viable options in the PRP injection protocol for treating knee osteoarthritis. CLINICAL

trial registrationClinical trial registration: IRCT20140907019073N5.

Indexed as

ArthralgiaOsteoarthritis, KneePlatelet-Rich PlasmaRange of Motion, ArticularAgedDouble-Blind MethodFemaleFollow-Up StudiesHumansInjections, Intra-ArticularMaleMiddle AgedPain MeasurementPhysical Functional PerformanceTreatment OutcomeDouble-centrifugedKnee osteoarthritisPlatelet-rich plasmaSingle-centrifuged

Identifiers

PMID41593810
PMCPMC13488654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.